BSE filing, NSE: NOVARTIND. Summary written from the filing by ALFA Finder's alert engine.
Novartis India Ltd: key numbers
- Share price
- ₹1,693.85
- Market cap
- ₹4,182 Cr
- Revenue (annual)
- ₹354.3 Cr
- Net profit (annual)
- ₹93.18 Cr
- P/E (TTM)
- 42.8×Sector 45.9×
- Promoter holding
- 70.68%+0.00% QoQ
- FII holding
- 1.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Novartis India Ltd
All →Novartis India Management Change
Evonile Pharma (formerly Novartis India) appointed Mr. Gagan Sharma as President – Specialty Business and Senior Management Personnel effective October 26, 2026. The filing is a Regulation 30 senior management appointment intimation.
Novartis India Other Announcement
Novartis India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations. This is a routine periodic disclosure.
Novartis India Annual General Meeting
Evonile Pharma (fka Novartis India) issued a postal ballot notice for shareholder votes on ESOP 2026 grant to the MD & CEO and creation of charge on assets. E-voting runs 14 Oct–12 Nov 2026.
Novartis India Fund Raise of ₹900 Cr
Evonile Pharma Limited approved a rights issue to raise up to ₹900 Crore. The company also formed a committee to manage the issuance terms.
- Value
- ₹900.0 Cr
Novartis India Credit Rating
Evonile Pharma Limited has received credit ratings from CARE Ratings Limited for its bank facilities. The company disclosed the ratings as part of its regulatory filings.
Novartis India Other Announcement
Novartis India Limited has changed its corporate name to Evonile Pharma Limited, effective October 01, 2026, following approval from the Ministry of Corporate Affairs.
Other board meeting date announcements
All →CHD Chemicals Board Meeting Date
CHD Chemicals intimated a board meeting on 04 Nov 2026 to consider unaudited half-yearly results for September 2026. Trading window remains closed until 06 Nov 2026.
Max Estates Board Meeting Date
Max Estates Limited has informed exchanges that its board will meet on 4 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The trading window stays closed until 6 November 2026.
GKP Printing & Packaging Board Meeting Date
G.K.P. Printing & Packaging announced a board meeting on 4 November 2026 to approve unaudited results for the quarter ended 30 September 2026. Trading window has been closed for insiders since 1 October 2026.
ADF Foods Board Meeting Date
ADF Foods will hold a board meeting on November 5, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The meeting will also consider an interim dividend for FY2026-27.
MKP Mobility Board Meeting Date
MKP Mobility will hold a board meeting on November 6, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window remains closed until 48 hours after results.
Earkart Board Meeting Date
Earkart Limited gave prior intimation of a board meeting on 5 November 2026 to approve half-year results and incorporate an Australian subsidiary. The trading window stays closed until 7 November 2026.